San Diego, CA, United States of America

Zhi-Liang Chu

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Zhi-Liang Chu

Introduction

Zhi-Liang Chu, based in San Diego, California, is a prominent inventor known for his significant contributions to the field of medical innovations. With an impressive portfolio of 18 patents, Chu has focused his research on advancements that target metabolic disorders and obesity through innovative pharmaceutical compositions and methodologies.

Latest Patents

Among his latest inventions is a patent for "Methods for identifying a GLP-1 secretagogue." This invention presents a novel combination of a BRS-3 agonist and a dipeptidyl peptidase IV (DPP-IV) inhibitor aimed at lowering blood glucose levels and increasing blood GLP-1 levels. This innovative approach holds potential for treating or preventing obesity and diabetes, as well as related health conditions. Additionally, he has developed a patent concerning "Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues." This work focuses on utilizing the GPR119 receptor to identify compounds that can stimulate PYY secretion, proving useful in treating a range of disorders such as bone-related conditions, metabolic disorders, and cancers.

Career Highlights

Zhi-Liang Chu has had a notable career, with his work spanning various esteemed organizations. He has made significant contributions during his tenure at Arena Pharmaceuticals, Inc. and The Burnham Institute, where he has been instrumental in pushing the boundaries of medical research. His innovative approach to understanding and treating conditions related to metabolic health has made him a respected figure in his field.

Collaborations

Throughout his career, Chu has collaborated with distinguished colleagues such as James N. Leonard and Robert M. Jones. These partnerships have helped foster a creative environment that enhances the development of groundbreaking inventions aimed at improving patient health outcomes.

Conclusion

Zhi-Liang Chu’s innovative spirit and dedication to research have led to substantial advancements in the medical field, particularly in the treatment of obesity and metabolic disorders. His contributions to pharmaceuticals through patented inventions not only highlight his exceptional skills as an inventor but also promise a positive impact on future health solutions. As he continues to explore new horizons in innovation, Zhi-Liang Chu remains a key figure in shaping the landscape of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…